ADAR1 Capital Management »

Apogee Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.4M 57k 58.74
2024-06-30 $1.6M 41k 39.35
2024-03-31 $399k 6.0k 66.45

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Rtw Investments
Driehaus Capital Management
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners

View all funds holding Apogee Therapeutics